| Roger D Porter, DPM | |
|
7579 Alexandria Pike, Alexandria, KY 41001-1041 | |
| (859) 635-6666 | |
| (859) 635-6607 |
| Full Name | Roger D Porter |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 29 Years |
| Location | 7579 Alexandria Pike, Alexandria, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265435093 | NPI | - | NPPES |
| P00141188 | Other | KY | RAILROAD MEDICARE |
| 80002397 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 239 (Kentucky) | Primary |
| 213ES0131X | Podiatrist - Foot Surgery | KY239 (Kentucky) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Elizabeth Edgewood | Edgewood, KY | Hospital |
| Provider Name | Northern Kentucky Family Foot Care Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1235132861 PECOS PAC ID: 2062400757 Enrollment ID: O20040503000676 |
News Archive
A majority of people experiencing chronic insomnia can experience a normalization of sleep parameters through the use of cognitive behavioral therapy for insomnia (CBT-I), according to a research abstract that will be presented on Tuesday, June 9, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies.
A new report on non-invasive prenatal testing by the UK's Nuffield Council on Bioethics expresses concerns about the way the test is being sold by private providers.
Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today announced that the operating subsidiary of TPI, Chengdu Tianyin Pharmaceutical, has submitted the application for the renewal of its High Tech Enterprise Status at Chengdu, Sichuan Province of China.
The Critical Path Institute announced today it has been awarded a U.S. Food and Drug Administration contract in support of ongoing development of novel clinical outcome assessments for pediatric asthma.
The New York Times: Johnson & Johnson has said it will "revamp its quality controls, creating a single framework for its drug, medical device and consumer health care divisions." The move comes after the drugmaker saw a number of recalls of its medicines, such as Tylenol and Motrin, as well as probes by a congressional committee and the FDA into actions at its McNeil Consumer Healthcare subsidiary.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Roger D Porter, DPM 6200 Pleasant Ave, Ste 3, Fairfield, OH 45014-4671 Ph: (513) 829-9333 | Roger D Porter, DPM 7579 Alexandria Pike, Alexandria, KY 41001-1041 Ph: (859) 635-6666 |
News Archive
A majority of people experiencing chronic insomnia can experience a normalization of sleep parameters through the use of cognitive behavioral therapy for insomnia (CBT-I), according to a research abstract that will be presented on Tuesday, June 9, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies.
A new report on non-invasive prenatal testing by the UK's Nuffield Council on Bioethics expresses concerns about the way the test is being sold by private providers.
Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today announced that the operating subsidiary of TPI, Chengdu Tianyin Pharmaceutical, has submitted the application for the renewal of its High Tech Enterprise Status at Chengdu, Sichuan Province of China.
The Critical Path Institute announced today it has been awarded a U.S. Food and Drug Administration contract in support of ongoing development of novel clinical outcome assessments for pediatric asthma.
The New York Times: Johnson & Johnson has said it will "revamp its quality controls, creating a single framework for its drug, medical device and consumer health care divisions." The move comes after the drugmaker saw a number of recalls of its medicines, such as Tylenol and Motrin, as well as probes by a congressional committee and the FDA into actions at its McNeil Consumer Healthcare subsidiary.
› Verified 5 days ago
Northern Kentucky Family Foot Care Inc Podiatrist Medicare: Medicare Enrolled Practice Location: 7579 Alexandria Pike, Alexandria, KY 41001 Phone: 859-635-6666 Fax: 859-635-6607 |